FindTrial
Sign In

Development of new biomarker to predict the response of anti-cancer drugs for lung cancer

Development of new biomarker to predict the response of anti-cancer drugs for lung cancer - Development of new biomarker to predict the response of anti-cancer drugs for lung cancer

Status
Unknown
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000024176
Enrollment
200
Registered
2016-09-26
Start date
2013-03-28
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

lung cancer

Interventions

None listed

Sponsors

Kochi Medical school, Kochi University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: the patients who take the surgical resection of lung cancer and who agreed to be enrolled in the current study

Exclusion criteria

Exclusion criteria: n/a

Design outcomes

Primary

MeasureTime frame
The correlation of the biomarker's status with the mutation status of lung cancer—

Countries

Japan

Contacts

Public ContactTakashi Anayama

Kochi Medical school, Kochi University Surgery II

anayamat@kochi-u.ac.jp088-880-2375

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026